![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Akkurt MO, Yalcin SE, Akkurt I, Tatar B, Yavuz A, Yalcin Y, et al. 2015. The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses. Journal of the Turkish German Gynecological Association 16:226–230.
- Alay I, Kaya C, Karaca I, Eren E, Hosgoren M, Aslanova F, et al. 2019. The effectiveness of neutrophil to lymphocyte ratio in prediction of medical treatment failure for tubo-ovarian abscess. Journal of Obstetrics and Gynaecology Research 45:1183–1189.
- Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. 2016. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ : official Publication of the State Medical Society of Wisconsin 115:317–321.
- Bugg CW, Taira T. 2016. Pelvic inflammatory disease: diagnosis and treatment in the emergency department. Emergency Medicine Practice 18:1–24.
- Dewitt J, Reining A, Allsworth JE, Peipert JF. 2010. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010:847041.
- Fouks Y, Cohen A, Shapira U, Solomon N, Almog B, Levin I. 2019. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. Journal of Minimally Invasive Gynecology 26:535–543.
- Gradison M. 2012. Pelvic inflammatory disease. American Family Physician 85:791–796.
- Granberg S, Gjelland K, Ekerhovd E. 2009. The management of pelvic abscess. Best Practice & Research. Clinical Obstetrics & Gynaecology 23:667–678.
- Habboub AY. 2016. Middlemore Hospital experience with tubo-ovarian abscesses: an observational retrospective study. International Journal of Women’s Health 8:325–340.
- Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D. 2003. Tubo-ovarian abscess in older women: is the woman’s age a risk factor for failed response to conservative treatment? Gynecologic and Obstetric Investigation 55:211–215.
- Keenan RT, Swearingen CJ, Yazici Y. 2008. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clinical and Experimental Rheumatology 26:814–819.
- Kinay T, Unlubilgin E, Cirik DA, Kayikcioglu F, Akgul MA, Dolen I. 2016. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment. International Journal of Gynecology & Obstetrics 135:77–81.
- Lee SW, Rhim CC, Kim JH, Lee SJ, Yoo SH, Kim SY, et al. 2015. Predictive markers of tubo-ovarian abscess in pelvic inflammatory disease. Gynecologic and Obstetric Investigation 81:97–104.
- Litao MK, Kamat D. 2014. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatric Annals 43:417–420.
- Mcneeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. 1998. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. American Journal of Obstetrics and Gynecology 178:1272–1278.
- Shusterman N, Kimmel PL, Kiechle FL, Williams S, Morrison G, Singer I. 1985. Factors influencing erythrocyte sedimentation in patients with chronic renal failure. Archives of Internal Medicine 145:1796–1799.
- Wiesenfeld HC, Sweet RL. 1993. Progress in the management of tuboovarian abscesses. Clinical Obstetrics and Gynecology 36:433–444.
- Yildirim M, Turkyilmaz E, Avsar AF. 2015. Preoperative neutrophil-to-lymphocyte ratio has a better predictive capacity in diagnosing tubo-ovarian abscess. Gynecologic and Obstetric Investigation 80:234–239.